Sjoerd H. Hofma, MD

Effectiveness of the Sirolimus-Eluting Stent in the Treatment of Saphenous Vein Graft Disease

08/01/2008

Francesco Saia , MD, PhD;

Angela Hoye , MB, MRCP, MD, MBChB;

Pedro A. Lemos , MD;

Patrick W. Serruys , MD, PhD;

Chourmouzios A. Arampatzis , MD;

Muzaffer Degertekin , MD;

Sjoerd H. Hofma , MD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Willem J. van der Giessen , MD, PhD;

Pim J. de Feyter , MD, PhD;

Ron T. van Domburg , PhD;

ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...

ABSTRACT: The use of bare stents...

08/01/2008

Journal of Invasive Cardiology

Sirolimus-eluting Stents for the Treatment of Atherosclerotic Ostial Lesions

08/01/2008

Patrick W. Serruys , MD, PhD;

Sjoerd H. Hofma , MD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Pieter C. Smits , MD, PhD;

Willem J. van der Giessen , MD, PhD;

Pim J. de Feyter , MD, PhD;

Ron T. van Domburg , PhD;

Jiro Aoki , MD;

Gaston A. Alfredo Rodriguez-Granillo , MD;

Andrew T.L. Ong , MD, MBBS, PhD;

Maniyal Vijayakumar ;

Angela Hoye , MB, MRCP, MD, MBChB;

Pedro A. Lemos , MD;

Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...

Ostial atherosclerotic lesions...

08/01/2008

Journal of Invasive Cardiology